These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
839 related articles for article (PubMed ID: 10219856)
1. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor betas and their receptors in human liver cirrhosis. Baer HU; Friess H; Abou-Shady M; Berberat P; Zimmermann A; Gold LI; Korc M; Büchler MW Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1031-9. PubMed ID: 9895050 [TBL] [Abstract][Full Text] [Related]
3. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma. Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta receptors in verrucous and squamous cell carcinoma. Anderson M; Muro-Cacho C; Cordero J; Livingston S; Muñoz-Antonia T Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):849-54. PubMed ID: 10448730 [TBL] [Abstract][Full Text] [Related]
5. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling. Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583 [TBL] [Abstract][Full Text] [Related]
7. Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma. Bristow RE; Baldwin RL; Yamada SD; Korc M; Karlan BY Cancer; 1999 Feb; 85(3):658-68. PubMed ID: 10091739 [TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100 [TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma. Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease. di Mola FF; Friess H; Scheuren A; Di Sebastiano P; Graber H; Egger B; Zimmermann A; Korc M; Büchler MW Ann Surg; 1999 Jan; 229(1):67-75. PubMed ID: 9923802 [TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of TGF-betas and their receptors in human acute pancreatitis. Friess H; Lu Z; Riesle E; Uhl W; Bründler AM; Horvath L; Gold LI; Korc M; Büchler MW Ann Surg; 1998 Jan; 227(1):95-104. PubMed ID: 9445116 [TBL] [Abstract][Full Text] [Related]
13. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia. Vivien D; Bernaudin M; Buisson A; Divoux D; MacKenzie ET; Nouvelot A J Neurochem; 1998 Jun; 70(6):2296-304. PubMed ID: 9603194 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration. Opperman LA; Galanis V; Williams AR; Adab K Orthod Craniofac Res; 2002 Feb; 5(1):5-16. PubMed ID: 12071374 [TBL] [Abstract][Full Text] [Related]
15. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast. Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614 [TBL] [Abstract][Full Text] [Related]
16. Changes in levels of mRNAs of transforming growth factor (TGF)-beta1, -beta2, -beta3, TGF-beta type II receptor and sulfated glycoprotein-2 during apoptosis of mouse uterine epithelium. Wada K; Nomura S; Morii E; Kitamura Y; Nishizawa Y; Miyake A; Terada N J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):367-75. PubMed ID: 9010342 [TBL] [Abstract][Full Text] [Related]
17. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma. Ueno T; Hashimoto O; Kimura R; Torimura T; Kawaguchi T; Nakamura T; Sakata R; Koga H; Sata M Int J Oncol; 2001 Jan; 18(1):49-55. PubMed ID: 11115538 [TBL] [Abstract][Full Text] [Related]
18. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition. Nishikawa Y; Wang M; Carr BI J Cell Physiol; 1998 Sep; 176(3):612-23. PubMed ID: 9699514 [TBL] [Abstract][Full Text] [Related]
19. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro. Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632 [TBL] [Abstract][Full Text] [Related]